hMatrix® ADM is indicated for use to replace damaged or inadequate integumental tissue.  It is indicated for homologous use only.  Specific uses of hMatrix® ADM include use as a wound covering, abdominal wall repair, breast reconstruction, and for use in supplemental support, reinforcement, or covering of tendons or periosteum. The successful treatment of deep wounds often requires the use of a dermoconductive graft material to facilitate formation of granulation tissue and aid in wound closure. One such graft material used for this purpose is allograft-derived acellular dermis. Acellular dermal matrices (ADM) are used as a primary grafting material that can replace damaged or inadequate dermal tissue while helping to reduce the size of the wound and providing protection to the site of injury. hMatrix ADM is an allograft derived from donated human skin. The dermis is processed using a proprietary method to remove the cells in order to maximize graft incorporation. The natural collagen and elastin matrix is ideal for neovascularization and cellular proliferation and has the potential to expedite the healing process. hMatrix^® ADM is provided as a sterile product with a device-level (SAL) of 10^-6.

Features

• Acellular dermal matrix (ADM)
• Superior suture retention strength*
• Flexible matrix for precise placement
• Decreased inflammatory response*
• Distributed as a frozen product
• Sterility assurance level (SAL) 10^-6
• 5 year shelf life
• Frozen storage